Eli Lilly said a late-stage trial of its new weight-loss drug showed it helped patients on high doses reduce their body weight by about a fifth raising hopes among doctors and investors that it could become a blockbuster treatment to tackle the global obesity epidemic.
礼来公司(Eli Lilly)表示，其新减肥药的后期试验显示，使用高剂量减肥药的患者减少了约五分之一的体重，这让医生和投资者对该药物可能成为解决manbetx app苹果 肥胖问题的重磅药物产生了希望。
您已阅读6%（358字），剩余94%（5267字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。